Chemical industry – Page 48
-
Business
Mexichem to buy Netafim in $1.5bn deal
Takeover brings Netafim’s smart irrigation technology that could be applied across other markets
-
Business
US firm fined for mishandling ammonia
Demakes will pay $130,000 to settle violations and has spent $300,000 upgrading systems
-
-
-
-
Business
Mylan settles Epipen overcharging allegations
Company will pay US Department of Justice $465m for avoiding paying rebates to government healthcare systems
-
Research
Fluorescent test strip detects deadly phosgene gas
Portable test checks for industrial gas leaks and chemical attacks
-
Opinion
Make room for randomness in drug development
Setting free the dark horses sometimes beats the most rational planning
-
Business
Airgas fined for fatal nitrogen leak at US sperm bank
$300,000 penalty for leak caused by over-pressurisation after Airgas failed to update tank safety label
-
Business
Chemical and pharma bosses quit US manufacturing council
President Trump disbands the group after multiple advisers resign in protest against his stance on racism
-
Webinar
Current topics in bioconjugation
Insights into making bioconjugates using optimal reagents and the latest techniques to create highly active and stable complexes
-
Feature
Environmentally benign by design
The challenge of designing drugs with biodegradability in mind
-
Business
US court denies Amgen appeal over Pfizer biosimilar
Amgen has lost its bid to compel Pfizer to divulge information about its version of anaemia drug Epogen
-
Business
Chemical companies urged to update cyber defences
Outdated technology is leaving chemical, energy and petrochemical facilities vulnerable to ransomware attacks
-
Business
Roche offloads majority of rights to lebrikizumab
Deal with Dermira could be worth well over $1 billion
-
Business
Carbon capture from air goes commercial
Companies hope to produce pure carbon dioxide straight from the atmosphere
-
Business
Bristol-Myers Squibb bags immunotherapy unicorn
Deal will add to pharma giant’s cancer portfolio
-
Business
GSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
-
Business
Genesis Energy to buy alkali business from Tronox
Tronox to spend proceeds on Cristal purchase
-
Business
Israeli company Haifa Chemicals shuttered
Lack of ammonia storage facility leads to colossal losses